Actualités Vaxcyte Inc - PCVX | Actions NASDAQ | ADVFN

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Vaxcyte Inc (PCVX)

81,99

1,02

(1,26%)

Fermé 31 Décembre 10:00PM

Retardé de 15 minutes

81,99

0,00

( 0,00% )

Avant marché: 1:00AM

Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Vaxcyte Initiates Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

-- Company Expects to Announce VAX-31 Infant Study Topline Safety, Tolerability and Immunogenicity Data from...

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs

-- VAX-31 Infant Indication: Investigational New Drug Application Cleared by FDA; Company Expects to...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

-- Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 1/2 Study of...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Azienda Gardesana Servizi

AMCI Acquisition Corpora...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales